Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06176469
NCT06176469
Active, not recruiting
Not Applicable

Population-level Prevalence, Effect on Quality of Life, and Treatment Behavior for Renal Colic and Urolithiasis in Poland

Mikolaj Przydacz1 site in 1 country10,000 target enrollmentDecember 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRenal ColicUrolithiasis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Renal Colic
Sponsor
Mikolaj Przydacz
Enrollment
10000
Locations
1
Primary Endpoint
Prevalence of renal colic and urolithiasis in Poland
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of this study is to analyze the prevalence, effect on quality of life, and treatment-related behaviors for renal colic and urolithiasis in a population-representative sample of Poles. We will be using an Internet interview format for renal colic and urolithiasis evaluation. The study will include respondents representative for age and place of residence with adequate proportions of respondents from urban and rural areas.

Registry
clinicaltrials.gov
Start Date
December 1, 2023
End Date
June 30, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Mikolaj Przydacz
Responsible Party
Sponsor Investigator
Principal Investigator

Mikolaj Przydacz

Associate Professor

Jagiellonian University

Eligibility Criteria

Inclusion Criteria

  • •consent to participate

Exclusion Criteria

  • •lack of consent to participate

Outcomes

Primary Outcomes

Prevalence of renal colic and urolithiasis in Poland

Time Frame: December 2023 - December 2024

Prevalence of renal colic and urolithiasis in Poland

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 2
prevalence of urinary incontinence and community interventio
CTRI/2018/03/012638none49
Recruiting
Not Applicable
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025Radiation ToxicityChemotherapeutic ToxicityChemotherapy-induced Peripheral NeuropathyDelayed Wound HealingChronic PainRefractory Pain
NCT05417737Bernardino Clavo, MD, PhD105
Completed
Not Applicable
Quality of Life of Patients With Locally Advanced and Metastatic Prostate CancerProstate Cancer
NCT02853409Ipsen628
Completed
Not Applicable
Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis PatientsPeritoneal DialysisHemodialysis, HomeHemodialysisQuality of LifeInformal CaregiversFamily CaregiversRenal Replacement TherapyKidney Failure, ChronicPatient Reported Outcome Measures
NCT05646615B.C. van Jaarsveld202
Completed
Not Applicable
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)Depressive Disorder, Major
NCT05841030Janssen Research & Development, LLC545